Evidence map›Paper›PMID 39201349›Full record

ArticleInternational journal of molecular sciences2024

Functional Characterization of Splice Variants in the Diagnosis of Albinism.

Modibo Diallo, Cécile Courdier, Elina Mercier, Angèle Sequeira, Alicia Defay-Stinat, Claudio Plaisant, Shahram Mesdaghi, Daniel Rigden, Sophie Javerzat, Eulalie Lasseaux and 11 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Molecular genetics and metabolism reports · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A patient with TPCN2-related hypopigmentation and ocular phenotype.European journal of human genetics : EJHG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Modibo DialloLaboratoire Maladies Rares, Génétique et Métabolisme, Bordeaux University, INSERM U1211, 33076 Bordeaux, France.ORCID 0009-0009-8884-7954
Cécile CourdierLaboratoire Maladies Rares, Génétique et Métabolisme, Bordeaux University, INSERM U1211, 33076 Bordeaux, France.
Elina MercierLaboratoire Maladies Rares, Génétique et Métabolisme, Bordeaux University, INSERM U1211, 33076 Bordeaux, France.
Angèle SequeiraLaboratoire Maladies Rares, Génétique et Métabolisme, Bordeaux University, INSERM U1211, 33076 Bordeaux, France.
Alicia Defay-StinatLaboratoire Maladies Rares, Génétique et Métabolisme, Bordeaux University, INSERM U1211, 33076 Bordeaux, France.
Claudio PlaisantService de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, 33076 Bordeaux, France.ORCID 0000-0002-1293-6717
Shahram MesdaghiInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK.
Daniel RigdenInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK.ORCID 0000-0002-7565-8937
Sophie JaverzatLaboratoire Maladies Rares, Génétique et Métabolisme, Bordeaux University, INSERM U1211, 33076 Bordeaux, France.ORCID 0000-0003-3497-0542
Eulalie LasseauxService de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, 33076 Bordeaux, France.
Laetitia BourgeadeService de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, 33076 Bordeaux, France.
Séverine Audebert-BellangerService de Génétique Médicale, Centre Hospitalier Universitaire de Brest, 29200 Brest, France.
Hélène DollfusService de Génétique Médicale, Centre Hospitalier Universitaire de Strasbourg, 67091 Strasbourg, France.
Smail Hadj-RabiaService de Dermatologie, Hôpital Necker-Enfants Malades, 75015 Paris, France.ORCID 0000-0001-6801-7106
Fanny Morice-PicardService de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, 33076 Bordeaux, France.ORCID 0000-0002-4316-916X
Manon PhilibertHôpital Fondation Rothschild, 75019 Paris, France.
Mohamed Kole SidibéInfirmerie Hôpital Militaire, Bamako BP 236, Mali.
Vasily SmirnovService d'Exploration Fonctionnelle de la Vision et de Neuro-Ophtalmologie, Centre Hospitalier Universitaire de Lille, 59037 Lille, France.ORCID 0000-0003-4172-514X
Ousmane SyllaInfirmerie Hôpital Militaire, Bamako BP 236, Mali.
Vincent MichaudLaboratoire Maladies Rares, Génétique et Métabolisme, Bordeaux University, INSERM U1211, 33076 Bordeaux, France.ORCID 0000-0002-5788-392X
Benoit ArveilerLaboratoire Maladies Rares, Génétique et Métabolisme, Bordeaux University, INSERM U1211, 33076 Bordeaux, France.ORCID 0000-0002-2987-2932

Funding

Agence Nationale de la Recherche ANR-21-CE17-0041-01
6 · The paper itself

Abstract

Albinism is a genetically heterogeneous disease in which 21 genes are known so far. Its inheritance mode is autosomal recessive except for one X-linked form. The molecular analysis of exonic sequences of these genes allows for about a 70% diagnostic rate. About half (15%) of the unsolved cases are heterozygous for one pathogenic or probably pathogenic variant. Assuming that the missing variant may be located in non-coding regions, we performed sequencing for 122 such heterozygous patients of either the whole genome (27 patients) or our NGS panel (95 patients) that includes, in addition to all exons of the 21 genes, the introns and flanking sequences of five genes,

Indexed as

AlbinismExonsAlternative SplicingFemaleHeterozygoteHumansIntronsMaleMutationRNA Splicingalbinismexon skippingminigene assaypseudoexonRT-PCRsplice variants

Identifiers

PMID39201349
PMCPMC11355033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.